INTERPACE BIOSCIENCES, INC. Cost of Reimbursable Expense (Deprecated 2018-01-31)
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Cost of Reimbursable Expense (Deprecated 2018-01-31) of $27.40 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-05.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfReimbursableExpense · last filed 2015-03-05
- INTERPACE BIOSCIENCES, INC. cost of reimbursable expense (deprecated 2018-01-31) for fiscal 2014 was $27.40M, a 11.04% decline from fiscal 2013.
- INTERPACE BIOSCIENCES, INC. cost of reimbursable expense (deprecated 2018-01-31) for fiscal 2013 was $30.80M, a 54.77% increase from fiscal 2012.
- INTERPACE BIOSCIENCES, INC. cost of reimbursable expense (deprecated 2018-01-31) for fiscal 2012 was $19.90M, a 19.76% decline from fiscal 2011.
- INTERPACE BIOSCIENCES, INC. cost of reimbursable expense (deprecated 2018-01-31) for fiscal 2011 was $24.80M.
| Period end | Cost of Reimbursable Expense (Deprecated 2018-01-31) 12 month |
|---|---|
| 2014-12-31 | $27.40M 10-K · filed 2015-03-05 |
| 2013-12-31 | $30.80M 10-K · filed 2015-03-05 |
| 2012-12-31 | $19.90M 10-K · filed 2014-03-06 |
| 2011-12-31 | $24.80M 10-K · filed 2013-03-15 |